Peritoneal Dialysis is Limited by Kidney and Liver Volume in Autosomal Dominant Polycystic Kidney Disease

We evaluated the influence of kidney volume (KV) and liver volume (LV) on continuation of peritoneal dialysis (PD) in patients with autosomal dominant polycystic kidney disease (PKD). Twenty‐two PKD patients on PD were retrospectively investigated after being divided into two groups. Group 1 comprised 15 patients who started PD at our hospital and group 2 was composed of seven patients referred from other hospitals for treatment of renomegaly by transcatheter arterial embolization (TAE) at 47.1 ± 21.8 months after commencing PD. In group 1, KV for both kidneys (mean ± SD) was 2787 ± 1945 mL (range: 1043 to 6816 mL), LV was 2198 ± 1139 mL (1005 to 4116 mL), and the total organ volume (TV = KV + LV) was 4985 ± 1815 mL (2320 to 8912 mL). In the patient with the largest TV from group 1 (KV of 6816 mL, TV of 8912 mL, and TV/BMI ratio of 426, PD was stopped due to dialysate leakage. However, dialysate leakage did not occur in the other 14 patients (TV ≦ 7963 mL and TV/BMI ratio of 353 at the start of PD). In group 2, KV was 5822 ± 1597 mL (3832 to 8862 mL), LV was 1776 ± 519 mL (1271 to 2671 mL), and TV was 7597 ± 1431 mL (5505 to 10358) before TAE. Leakage of dialysate did not occur with a mean infusion volume of 1530 ± 370 mL (1000 mL to 2000 mL), even after renomegaly and hepatomegaly progressed to the maximum TV/BMI ratio of 359. Six patients from the two groups developed new abdominal hernias at 36 ± 5 months (6–55 months) after starting PD. These findings suggest that performance of PD may be limited by renomegaly and hepatomegaly in patients with PKD.

[1]  Y. Ubara,et al.  Successful peritoneal dialysis after renal transcatheter arterial embolization in autosomal dominant polycystic kidney disease. , 2011, American Journal of Kidney Diseases.

[2]  B. C. Kwan,et al.  Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Sanjeev Kumar,et al.  Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis. , 2008, Kidney international.

[4]  Y. Ubara,et al.  Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  Y. Ubara New Therapeutic Option for Autosomal Dominant Polycystic Kidney Disease Patients With Enlarged Kidney and Liver , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[6]  R. Selgas,et al.  Risk Factors for Abdominal Wall Complications in Peritoneal Dialysis Patients , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  Y. Ubara,et al.  Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  A. D. de Vecchi,et al.  Polycystic Kidney Disease and Late Peritoneal Leakage in CAPD: Are They Related? , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  B. Haraldsson,et al.  Capd in Patients with Autosomal Dominant Polycystic Kidney Disease , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  J. Turney,et al.  Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  S. Hariharan,et al.  Renal replacement therapy in autosomal dominant polycystic kidney disease. , 1991, Nephron.

[12]  P. Meech,et al.  Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis. , 1986, The New Zealand medical journal.